NYSE:HUM
-
Humana Faces Valuation Split Following 2026 Guidance Cut
Humana has lowered its 2026 full-year earnings guidance as tightening Medicare Advantage regulations pressure margins, sparking a divide among analysts over the stock’s true value.
Humana has lowered its 2026 full-year earnings guidance as tightening Medicare Advantage regulations pressure margins, sparking a divide among analysts over the stock’s true value.